Blog
Nonviral CAR-T is ‘remarkably safe’ and clinically active in B-cell ALL
CARCIK-CD19, an investigational therapy developed by scientists in Italy, involves
March 24, 2022
Menu
CARCIK-CD19, an investigational therapy developed by scientists in Italy, involves
The mammalian brain contains many specialized cells that develop from
CRISPR genome editing has served as a powerful tool to
Clinicians treating patients with CAR T cells have become adept
The adoptive transfer of T lymphocytes reprogrammed to target tumour
CAR-M is a therapy that begins with the isolation of
For 17 years, Thomas Blankenstein has been working on his
A group of researchers set out to characterize the genotypic
CAR-T cell therapy, which received FDA approval in 2017, are
